Observational studyThe journal of headache and pain2022

Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study.

Christopher Kjaer Cullum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.